In vitro inhibitory effect of maraviroc on the association of the simian immunodeficiency virus envelope glycoprotein with CCR5
- 5 January 2021
- journal article
- research article
- Published by Springer Nature in Virus Genes
- Vol. 57 (1) , 106-110
Abstract
Asian macaques infected with simian immunodeficiency viruses (SIVs) isolated from African non-human primates develop a disease similar to human AIDS. SIV enters its target cells by binding to CD4 and a coreceptor, typically CCR5. Maraviroc is an entry inhibitor of human immunodeficiency virus type 1 (HIV-1) that prevents the interaction between CCR5 and the surface subunit gp120 of the viral envelope glycoprotein (Env). Thus far, the activity of maraviroc on SIV entry has been poorly studied. Here, we determined in vitro pharmacological parameters of the effect of maraviroc on the SIV Env association with CCR5. Cell-to-cell fusion inhibition assays were used to compare the susceptibility to maraviroc of the SIVsmmPBj Env-CCR5 interaction with that of HIV-1BaL Env. Analysis of dose–response curves and determination of IC50 values demonstrate that increasing concentrations of maraviroc inhibit the membrane fusion activity of SIVsmmPBj Env in a manner and to an extent similar to that of HIV-1BaL Env.Keywords
Funding Information
- Consejo Nacional de Investigaciones Científicas y Técnicas
This publication has 34 references indexed in Scilit:
- Understanding the Process of Envelope Glycoprotein Incorporation into Virions in Simian and Feline Immunodeficiency VirusesViruses, 2014
- Nonhuman primate models in AIDS researchCurrent Opinion in HIV and AIDS, 2013
- In VitroPhenotypic Susceptibility of HIV-2 Clinical Isolates to CCR5 InhibitorsAntimicrobial Agents and Chemotherapy, 2012
- Origins of HIV and the AIDS PandemicCold Spring Harbor Perspectives in Medicine, 2011
- HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and IncorporationJournal of Molecular Biology, 2011
- Protection of Rhesus Macaques from Vaginal Infection by Vaginally Delivered Maraviroc, an Inhibitor of HIV‐1 Entry via the CCR5 Co‐ReceptorThe Journal of Infectious Diseases, 2010
- Effects of Partial Deletions within the Human Immunodeficiency Virus Type 1 V3 Loop on Coreceptor Tropism and Sensitivity to Entry InhibitorsJournal of Virology, 2008
- Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virionsProceedings of the National Academy of Sciences, 2003
- Unique lentivirus-host interactions: SIVsmmPBj14 infection of macaquesVirus Research, 2002
- Expression of CD4 Controls the Susceptibility of THP-1 Cells to Infection by R5 and X4 HIV Type 1 IsolatesAIDS Research and Human Retroviruses, 2002